$CLRO Income Statement | Understand Stock

$CLRO

$5.57 +$0.58 (11.62%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenue
Cost of goods sold
Gross profit
Operating expenses:
Sales and marketing
Research and product development
General and administrative
Legal expense
Professional fees
Total operating expenses
Operating loss
Interest expense
Interest income (expense), net
Other income, net
Loss from continuing operations before income taxes
Provision for income taxes
Loss from continuing operations
Loss from discontinued operations, net of tax
Net loss
Unrealized gain (loss) on available-for-sale securities, net of tax
Unrealized loss on available-for-sale securities, net of tax
Other comprehensive loss:
Unrealized gain (loss) on available-for-sale securities, net of tax
Change in foreign currency translation adjustment
Comprehensive loss
Basic loss per common share
From continuing operations (in dollars per share)
From discontinued operations (in dollars per share)
Total (in dollars per share)
Diluted loss per common share
From continuing operations (in dollars per share)
From discontinued operations (in dollars per share)
Total (in dollars per share)
Basic weighted average shares outstanding (in shares)
Diluted weighted average shares outstanding (in shares)

Comments